SCHEMBL24315840

SCHEMBL24315840

C=CC1(c2ccc3c4c(ccnc24)N(C2CCC(=O)NC2=O)C3=O)CCN(Cc2ccccc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
IKZF2 Q9UKS7 4/20 0.44
CRBN Q96SW2 14/20 0.41
DDB1 Q16531 9/20 0.41
IKZF1 Q13422 2/20 0.39
IKZF3 Q9UKT9 9/20 0.39
ALDH1A1 P00352 1/20 0.39
CHRM2 P08172 1/20 0.39
OPRM1 P35372 1/20 0.39
CYP1A2 P05177 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24315750 0.88 IKZF2 (0.46) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL24315922 0.88 IKZF2 (0.46) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL26664956 0.84 IKZF2 (0.44) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL24315977 0.83 DDB1 (0.43) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL26664951 0.83 IKZF2 (0.43) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL24315676 0.83 IKZF2 (0.43) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL24315760 0.83 CRBN (0.51) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL24315901 0.82 IKZF2 (0.57) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL29611199 0.82 IKZF2 (0.57) IKZF2CRBNDDB1IKZF1IKZF3
SCHEMBL24315891 0.80 IKZF2 (0.48) IKZF2CRBNDDB1IKZF1IKZF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed